As the running costs for the assay are mainly related to the plasticware of the PCR step, thanks to gene therapy funding and generous enzyme availabilty from David Warren of the Central Lab, we will in an initial phase try to provide the service for free for Norwegian academic institutions, provided allele frequency information may be displayed at the SNP information site. For larger projects, we would also like to point to the National FUGE SNP facility, Cigene. For further information, please contact Karen-Marie Heintz, Per Olaf Ekstrøm or Eivind Hovig.
A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases
Transl Oncol, 12 (7), 951-958
Roadmap for a precision-medicine initiative in the Nordic region
Nat Genet, 51 (6), 924-930
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation
Br J Cancer (in press)